MRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic ... defending the body ...
Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, around age 65, and what ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Computational tool improves recombinant virus design efficiency and yield.This innovative in-house development is a key component of Transgene’s ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback